BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 546729)

  • 1. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum ceruloplasmin levels in patients of leukaemias, Hodgkin's and non-Hodgkin's lymphomas.
    Aggarwal AK; Sanwalka AB; Vadehra PL; Prabhakar BR
    Indian J Pathol Microbiol; 1984 Oct; 27(4):347-52. PubMed ID: 6534868
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
    Casamassima A; Addabbo L; Caporusso L; Lorusso V
    Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum copper levels in malignant lymphomas].
    Peng JF; Wu KC
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):74-6, 124. PubMed ID: 3987447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum copper levels in Hodgkin's disease].
    Cohen Y; Epelboim R; Haim N; Zinder O
    Harefuah; 1984 Mar; 106(6):252-4. PubMed ID: 6745761
    [No Abstract]   [Full Text] [Related]  

  • 11. Discriminant analysis of Hodgkin's disease and non-Hodgkin's lymphomas by age and serum proteins.
    Merucci P; Taggi F; Marolla A; Abbolito MR; Vitelli G; Marolla P; Meliffi L; Chiarotti F; Ippolito FM; Ameglio F
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1243-7. PubMed ID: 6567527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged observations on variations in the serum copper in Hodgkin's disease.
    Warren RL; Jelliffe AM; Watson JV; Hobbs CB
    Clin Radiol; 1969 Jul; 20(3):247-56. PubMed ID: 5808043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum copper content and ceruloplasmin activity in children with lymphogranulomatosis].
    Dmitrieva LV
    Vopr Okhr Materin Det; 1967 Feb; 12(2):37-40. PubMed ID: 5611374
    [No Abstract]   [Full Text] [Related]  

  • 14. Interpreting serum copper levels in Hodgkin's disease.
    Hrgovcic MJ; Tessmer CF; Mumford DM; Ong PS; Gamble JF; Shullenberger CC
    Tex Med; 1975 Feb; 71(2):53-63. PubMed ID: 1111152
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum copper in Hodgkin's disease: its relation to the anatomopathological variety, status and general signs].
    Aragón de la Cruz G; Otero Luna J; Criado Ortíz M; Polo Tolosana E
    Rev Clin Esp; 1975 Aug; 138(3):225-30. PubMed ID: 1178970
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood ceruloplasmin levels in acute lymphoblastic leukemia and Hodgkin's disease in childhood].
    Masi M; Vecchi V; Vivarelli F; Paolucci P
    Minerva Pediatr; 1975 Jun; 27(22):1223-8. PubMed ID: 1056499
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correlation between blood serum copper levels and ceruloplasmin activity in ischemic heart disease].
    Kondurtsev VA
    Ter Arkh; 1970 Nov; 42(11):30-2. PubMed ID: 5532718
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic changes in red blood cells in malignant lymphomas.
    De Bellis R; Boulard MR; Kasdorf H; Rodriguez I; Ferrando R; Di Landro J; Ferrari M; Sanguinett CM; Tanzer J
    Br J Haematol; 1979 May; 42(1):35-9. PubMed ID: 465359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sialyltransferase in hypercupraemia of non-Hodgkin's lymphoma.
    Shah I; Chou T; Tapazoglou E; Kessel D
    Scand J Haematol; 1984 Mar; 32(3):332-4. PubMed ID: 6701469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.